“…It was pre‐established that proinflammatory cytokines like TNF‐α and interleukin‐6 (IL‐6) become attractive targets for adjuvant treatment of cancer as they are master regulators of tumor‐related inflammation and tumorigenesis (Grivennikov & Karin, ). As per showed in Figure , alkaloids with pyrano[3,2‐c]pyridone and pyrano[3,2‐c]quinolone like fusaricide (1, Figure ) (McBrien et al., ), melicobisquinolinone‐B (2, Figure ) (Kamperdick, Van, Van Sung, & Adam, ), zanthosimuline (3, Figure ), and huajiaosimuline (4, Figure ) (Chen et al., ) referred as potential anticancer agents. Additionally, Quinolactin‐A (Sasaki et al., ) (5, Figure )—a 4‐quinolone alkaloid, isolated from the cultured broth of Penicillium sp.…”